Skip to main content
Clinical Trials/ACTRN12620000227998
ACTRN12620000227998
Recruiting
未知

A pilot randomised trial evaluating the effect of CUTICERIN® with or without a Regenerative Epithelial Suspension (RES™), on pigmentation of paediatric, split-thickness skin graft donor sites: The DRESSIng Trial, a pilot randomised trial.

Department of Industry , Innovation and Science0 sites40 target enrollmentFebruary 24, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Department of Industry , Innovation and Science
Enrollment
40
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2020
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Industry , Innovation and Science

Eligibility Criteria

Inclusion Criteria

  • 1\.Acute burn injury requiring a split thickness skin graft for which:
  • a.The donor site for evaluation should not exceed 320 sqcm.
  • b.The split\-thickness skin graft recipient site for evaluation should not exceed 400 sqcm.
  • 2\.Child (and/or accompanying guardian) is willing and able to complete all follow\-up evaluations required by the study protocol.

Exclusion Criteria

  • Non\-English\-Speaking Background
  • 2\.Child in the care of the Department of Community Services
  • 3\.Full thickness skin graft
  • 4\.Hypersensitivity to trypsin or sodium lactate.
  • 5\.Previous adverse reaction to general anaesthesia.

Outcomes

Primary Outcomes

Not specified

Similar Trials